Study,                  Year,PMID,experimental_events,experimental_total,control_events,control_total,treat1,treat2
Ridker (PREVENT),2003,12601075,14,255,37,253,Warfarin for INR 1.5 to 2.0,Placebo
Kearon (ELATE),2003,12917299,6,369,16,369,Warfarin for INR 2.0 to 3.0,Warfarin for INR 1.5 to 2.0
Becattini (WARFAS),2012,22621626,28,205,43,197,Aspirin 100 mg daily,Placebo
Brighton (ASPIRE),2012,23121403,57,411,73,411,Aspirin 100 mg daily,Placebo
Wetiz (EINSTEIN CHOICE),2017,28316279,13,1127,50,1131,Rivaroxaban 10 mg,Aspirin 100 mg daily
Agnelli (AMPLIFY-EXT),2013,23216615,14,840,73,829,Apixiban 2.5 mg,Placebo
Schulman (RE-MEDY),2013,23425163,26,1430,18,1426,Dabigatran 150 mg twice daily,Warfarin for INR 2.0 to 3.0
Schulman (RE-SONATE),2013,23425163,3,681,37,662,Dabigatran 150 mg twice daily,Placebo
